A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Assessing the Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women Undergoing an Assisted Reproductive Technology Programme
Latest Information Update: 26 Aug 2023
Price :
$35 *
At a glance
- Drugs Follitropin delta (Primary) ; Follitropin beta
- Indications Endometriosis; Female infertility
- Focus Registrational; Therapeutic Use
- Acronyms STORK
- Sponsors Ferring Pharmaceuticals
- 21 Oct 2020 Results presented at the American Society for Reproductive Medicine Scientific Congress 2020
- 21 Oct 2020 Results of post-hoc analysis from two clinical studies: NCT03228680 and NCT01956110 assessing similar ovarian response with individualized follitropin delta dosing regimen in Japanese and non-Japanese IVF/Icsi patients presented at the American Society for Reproductive Medicine Scientific Congress 2020
- 21 Aug 2019 Status changed from active, no longer recruiting to completed.